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Abstract: Longevity in humans is determined by multiple environmental and genetic factors. We have investigated possible
associations between longevity and Single Nucleotide Polymorphisms (SNPs) in the p21 (CDKN1A) gene, a stress‐inducible
senescence‐associated cell cycle inhibitor, expression of which upregulates genes implicated in several age‐related
diseases. By sequencing the promoter and exons of p21 in genomic DNA of ten individuals over 90 years old, we have
identified 30 SNPs, many of which had not been previously characterized. A cluster of minor alleles within the ‐4547/‐3489
bp region did not alter the basal activity or p53 responsiveness of the p21 promoter. We then compared the frequency of
41 p21 SNPs between 184 centenarians and 184 younger subjects in the Italian population. Rare alleles of two exon‐
derived SNPs, rs1801270 and rs1059234, were significantly under‐represented among the centenarians; no significant
differences were found for 39 non‐exonic SNPs. SNP rs1801270 causes Ser to Arg substitution at amino acid 31 and SNP
rs1059234 leads to a nucleotide change in the 3’‐untranslated region. Previous studies showed that the rare alleles of these
two SNPs may play a role in cancer. These p21 alleles may be potentially detrimental to longevity and therefore are rare in
centenarians.

INTRODUCTION

factors are likely to contribute. Centenarians are often
spared from age-related diseases, such as cardiovascular
disease, Alzheimer’s disease, diabetes mellitus, and
cancer. The rate of aging and maximum lifespan varies

Longevity in humans is believed to be a multifactorial
condition to which both genetic and environmental
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among species, and therefore it has been postulated to
be at least in part under genetic control [1-2].
Epidemiological data indicate the presence of a strong
familiar component of longevity that is largely
determined by genetics. Thus, progeroid syndromes of
accelerated aging have known genetic causes [3-4]. A
number of possible associations between longevity and
allelic variants of genes have been described. Estimates
of the heritability of human lifespan vary from 10-50%
with the most common finding being that about a third
of human lifespan may be heritable. The rest is due to
environmental exposure, accidents and injuries, lifestyle
and chance. Very long life, to beyond the age of 90
years, appears to have an even stronger genetic basis
[5], which explains why centenarians and nearcentenarians tend to cluster in families.

RESULTS
Analysis strategy
To determine if any polymorphic variants of p21 that
change either its amino acid sequence or regulation of
its transcription may be differentially represented in the
long lived individuals (LLI), we carried out this study in
several steps. First, in the pilot study, we sequenced the
three exons of the p21 gene and a 5-kb stretch of its
promoter sequence in the DNA from ten LLI > 90 y.o.
(Americans of European descent) to identify SNPs in
these regions. To determine if the identified SNPs are
specific for LLI, we then used the Sequenom SNP
analysis strategy to determine the frequencies of these
SNPs in a population of 92 non-LLI individuals
(Utah/CEPH population). Finally, in the ethnicitymatched large scale analysis, we used the Sequenom
strategy to determine the frequencies of p21 SNPs in
ethnically matched Italian populations of 184 LLI and
184 non-LLI control subjects.

Theories on aging postulate that aging is a remodeling
process, where the body of survivors progressively
adapts to internal and external damaging agents, to
which they are exposed over several decades. Thus,
stress response and adaptation mechanisms play a
fundamental role in the aging process and have an
impact on individual lifespan. Centenarians’ capability
to live such extraordinarily long lives is in large part
due to genetic variations that either affect the rate of
aging or decrease the susceptibility to age-associated
diseases.

SNPs of the p21 promoter identified by sequence
analysis
As the first approach, we undertook the sequencing of
the three p21 exons and a 5-kb sequence upstream of
the p21 transcription start site in the genomic DNA
from ten LLI. Comparison with the human genome
database sequence revealed only one SNP within the
three exons, an A->C transversion in codon 31 causing
Arg -> Ser substitution (rs1801270). This SNP was
previously known and the frequency of the minor allele
among the LLI was 0.28 (5/18), which was similar to
the minor allele frequency of 0.24 in the general
population (unstratified for ethnicity), reported at that
time for this SNP in the NCBI database. Promoter
sequencing yielded a total of 29 SNPs. Only six of the
promoter SNPs had known frequencies reported in the
NCBI database, 17 others had been reported but not
characterized, and six other promoter SNPs had not
been previously reported. To determine the frequencies
of the promoter SNPs in a non-LLI population, 25 of
these SNPs were assayed in 92 younger Utah/CEPH
individuals using Sequenom MassARRAY® system.
The positions and allele frequencies for all the SNPs
identified in the promoter are presented in Table 1.
Notably, we found ten SNPs that were strongly
associated with each other in the Utah/CEPH population
(rs4711458, rs471459, rs4711461, rs4714002, rs471146,
rs4714003, rs56850951, rs10947623, rs12192827,
rs12192877), in the region between -4547 bp and -3489
bp, where a novel p53 binding site has been recently
found [7]. We have found that a cluster of minor alleles

Some of the most promising candidate genes appear to
be those involved in stress response. An interesting
possible candidate is p21 (CDKN1A) which has been
shown to be involved both in stress response
mechanisms and in the expression of genes implicated
in age-related diseases. p21 is best known as a stressinducible cyclin-dependent kinase inhibitor, which
triggers cell growth arrest associated with senescence
and damage response. Some evidence suggests that the
effects of p21 induction on gene expression in senescent
cells may contribute to the pathogenesis of cancer and
age-related diseases. In particular, p21 expression was
found to upregulate multiple genes that have not only
been associated with senescence but also implicated in
age-related diseases, including Alzheimer's disease,
atherosclerosis, amyloidosis, arthritis and cancer, thus
suggesting that p21 induction by stress may play a
causal role in these diseases [6]. The role of p21 in cell
senescence and its possible implication in the risk of
age-related diseases suggests that allelic variations in
this gene may have an impact on the lifespan. The goal
of this study was to identify p21 polymorphisms and to
determine whether they may be associated with
longevity.
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within the -4547/-3489 bp region was more common in
the ten LLI samples compared to the Utah/CEPH
population. The frequencies of the rare allele-carriers
(almost all heterozygotes) was 50% among the ten LLIs

SNP

rs4711458
rs4711459
rs4711461
rs4714002
rs471146
rs4714003
rs56850951
rs10947623
rs12192827
rs12192877
CDKN1A11
CDKN1A12
CDKN1A13
rs9394371
rs4135234
rs3829963
rs3829964
rs3829965
rs4135237
rs3829966
rs3829967
rs3829968
rs733590
rs762623
rs2395655
rs730506
rs4151702
rs4135239
CDKN1A29

Location in the
chromosome
36749919
36750002
36750146
36750164
36750168
36750238
36750380
36750814
36750949
36750977
36751056
36751203
36751481
36751733
36752199
36752364
36752475
36752488
36752868
36752929
36752936
36752943
36753181
36753444
36753674
36753946
36753966
36754331
36754348

Rare
allele
C
C
T
T
A
T
T
A
T
A
G
G
A
T
A
A
C
G
T
T
C
C
C
A
G
C
C
C
+C

and 23% for the Utah/CEPH population. This difference
did not reach statistical significance (P< 0.158 t-test). No
significant differences between these two populations
were found for the other SNPs in the promoter region.

Frequency of
rare allele
in LLI
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.22
0.27
0.25
0.10
0.25
0.11
0.11
0.12
0.27
0.45
0.27
0.25
0.07
0.07
0.07
0.06
0.31
0.27
0.11
0.11
0.13
1.00

Frequency of
rare allele in
controls
0.115
0.115
0.098
0.885
0.904
0.119
NA
0.118
0.120
0.080
0.070
NA
0.000
0.110
0.070
0.100
0.400
0.110
0.000
0.070
0.100
0.070
0.000
0.290
0.320
0.190
0.200
NA
NA

Common
Allele
T
T
C
G
G
C
C
G
C
C
A
A
G
C
G
C
T
A
G
C
T
T
T
G
A
G
G
G

Table 1. Summary of statistics for SNPs identified in the pilot study.
Strongly associated SNPs in the Utah/CEPH population are shown in italics.
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Figure 1. Activities of the p21 promoter‐luciferase constructs with the common (p21C‐luc; black bars) or rare
(p21R‐luc; grey bars) allele SNP cluster in the ‐4547/‐3489 bp region. (A) Three independent plasmid preparations
of each of p21C‐luc or p21R‐Luc (R) were transfected into HCT116 wild type (WT) cells. Cells were harvested 48 h
after transfection, and firefly luciferase activity was measured and normalized to Renilla luciferase expressed
from a co‐transfected construct. The bars show mean and standard deviation for triplicate transfections. (B)
p21C‐luc and p21R‐luc plasmids were transfected in parallel into HCT116 WT and p53‐/‐ cell lines, in triplicates as
in A. The bars show mean and standard deviation of the ratio of normalized luciferase activities achieved with the
same plasmid in the WT relative to p53‐/‐ cells.

the p21 promoter could have a different response to
p53, we transfected one preparation of each plasmid
into wild-type HCT116 cells and into the HCT116
derivative with the knockout of both p53 alleles [8]. The
two plasmids showed equal (two-fold) reduction in the
promoter activity in p53-knockout cells (Figure 1B),
indicating that the LLI-derived promoter had essentially
unaltered response to p53.

A cluster of minor alleles in the p21 promoter does
not alter its basal activity and p53 responsiveness
Since ten rare SNPs within the region between -4547 bp
and -3489 bp, comprising a p53 binding site, were
found at a higher frequency among the ten LLI relative
to the Utah/CEPH population, we were interested to
determine if the presence of these minor alleles affects
the basal activity or p53 dependence of the p21
promoter. A 2.1-kb fragment containing a cluster of the
minor alleles in this region was amplified by PCR from
the genomic DNA of one LLI and cloned into the
plasmid p21-PGL.4.10-luc-, which contains 5 kb of the
p21 promoter driving the expression of the firefly
luciferase reporter gene [7], replacing the common
alleles in the corresponding promoter region. The
resulting plasmid was designated p21R-Luc. To
compare the basal activities of the rare-allele p21R-Luc
and the common-allele p21-PGL.4.10-luc construct
(designated p21C-Luc in Fig. 1), three independent
preparations of each plasmid were transfected into wildtype HCT116 colon carcinoma cells, together with a
Renilla luciferase expressing vector (normalization
standard). Normalized firefly luciferase expression from
the two plasmids was indistinguishable, indicating
unaltered basal activity of the LLI-derived promoter
(Figure 1A). To determine whether the two variants of

www.impactaging.com

Large scale analysis of p21 SNPs: correlations with
longevity in the Italian population
A comparison of allelic frequencies between the first
two population samples that we analyzed, ten LLI from
Americans of European origin and younger individuals
of the Utah/CEPH population, is inevitably biased by
the small sample size of the LLI set and by historically
limited variability in the founder pool of the Utah
population. Consequently the SNP frequencies could be
affected not only by longevity but could also have the
founder pool as an uncontrolled confounder. This is an
issue typical in genetic association studies affected by
the phenomena of ‘stratification’: the failure to
adequately match the genetic background of cases and
controls. Therefore, to minimize this problem, in the
large scale analysis we only used DNA from
centenarians (mean age 100.88±1.77 years) and younger
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(38.97±12.21 years) subject populations of Italian origin
(184 subjects each), selected for similar origins in
Central Italy and representing ethnically matched
populations. We undertook this large case-control
design study to (i) verify frequencies of the SNPs
identified in the pilot study, (ii) create a haplotype map

SNP

rs6457931
rs1321312
rs4331968
rs9470367
rs6920453
rs9462209
rs4713999
rs1321309
rs4711459
rs4711461
rs4714003
CDKN1A
rs10947623
rs12192827
rs12192877
rs4135234
rs3829963
rs3829965
rs4135237
rs3829966
rs3829967
rs733590
rs762623
rs2395655
rs730506
rs4151702
rs3176343
rs3176344
rs3176349
rs1801270
rs1059234
rs876581
rs6457938

Location in
the
chromosome
36721790
36730852
36731221
36734910
36735461
36736020
36741047
36746614
36750002
36750146
36750238
36750804
36750814
36750949
36750977
36752199
36752364
36752488
36752868
36752929
36752936
36753181
36753444
36753674
36753946
36753966
36758245
36758525
36759355
36759949
36761575
36763423
36768431

Rare
allele
G
G
T
C
T
G
A
T
C
T
T
G
A
T
A
A
A
G
T
T
C
C
A
G
C
C
A
A
T
A
T
A
A

Frequency
rare allele
in LLI
0.450
0.155
0.299
0.323
0.228
0.466
0.413
0.440
0.153
0.163
0.086
0.156
0.165
0.156
0.158
0.151
0.135
0.161
0.158
0.146
0.261
0.452
0.161
0.479
0.245
0.257
0.044
0.018
0.028
0.043
0.049
0.056
0.309

of 60,000 bp, and (iii) determine whether any specific
SNPs and haplotypes are associated with longevity. In
addition to 17 of our SNPs identified in the pilot study,
30 SNPs spanning the p21 gene were selected from the
SNP HapMap consortium database, for a total of 47
SNPs included in the genotyping.

Frequency
rare allele
in controls
0.447
0.198
0.282
0.321
0.207
0.411
0.459
0.400
0.139
0.136
0.092
0.181
0.126
0.122
0.134
0.180
0.136
0.142
0.171
0.169
0.212
0.458
0.188
0.504
0.252
0.254
0.075
0.043
0.053
0.093
0.098
0.092
0.290

Common
Allele

CHISQ

P

T
C
A
G
C
T
G
C
T
C
C
A
G
C
C
G
C
A
G
C
T
T
G
A
G
G
G
G
G
C
C
G
G

0.006
1.790
0.200
0.004
0.382
1.452
1.098
0.965
0.200
0.826
0.072
0.667
1.652
1.367
0.679
0.895
0.002
0.378
0.160
0.586
1.974
0.025
0.705
0.335
0.035
0.008
2.597
3.069
2.091
5.412
4.983
2.653
0.255

0.936
0.181
0.655
0.949
0.537
0.228
0.295
0.326
0.655
0.364
0.789
0.414
0.199
0.242
0.410
0.344
0.969
0.539
0.689
0.444
0.160
0.875
0.401
0.563
0.852
0.930
0.107
0.080
0.148
0.020
0.026
0.103
0.614

OR

1.014
0.746
1.086
1.012
1.134
1.254
0.829
1.177
1.115
1.238
0.921
0.834
1.366
1.332
1.218
0.809
0.990
1.158
0.913
0.839
1.313
0.973
0.827
0.904
0.964
1.017
0.561
0.396
0.526
0.437
0.472
0.583
1.096

Table 2. Summary of statistics. Large scale analysis of Italian populations. SNPs showing significant differences
between the control and LLI populations are shown in boldface; SNPs comprising the sixth haplotype block are italicized.
CHISQ=Chi Square, P=P value, OR= Odds Ratio
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Haplotype

Frequency
LLI

Block 6
FOUR SNP WINDOW
AGGA
0.03725
GGGA
0.01198
GGTC
0.02854
GAGC
0.01811
GGGC
0.90410
SIX SNP WINDOW
AGGATA
0.03198
GGGATA
0.01050
GGTCCG
0.02906
GAGCCG
0.01844
GGGCCG
0.91000

Frequency
controls

P value

SNPs

0.07798
0.01181
0.05105
0.03977
0.81940

0.03972
0.98520
0.17610
0.12820
0.00394

rs3176343|rs3176344|rs3176349|rs1801270
rs3176343|rs3176344|rs3176349|rs1801270
rs3176343|rs3176344|rs3176349|rs1801270
rs3176343|rs3176344|rs3176349|rs1801270
rs3176343|rs3176344|rs3176349|rs1801270

0.07607
0.01284
0.05134
0.03970
0.82000

0.02249
0.80000
0.18560
0.13900
0.00211

rs3176343|rs3176344|rs3176349|rs1801270|rs1059234|rs876581
rs3176343|rs3176344|rs3176349|rs1801270|rs1059234|rs876581
rs3176343|rs3176344|rs3176349|rs1801270|rs1059234|rs876581
rs3176343|rs3176344|rs3176349|rs1801270|rs1059234|rs876581
rs3176343|rs3176344|rs3176349|rs1801270|rs1059234|rs876581

Table 3. Frequencies and P‐values for the sixth p21 haplotype containing SNPs rs1801270 and rs1059234
in the centenarian and control Italian populations.

SNPs rs1801270 and rs1059234 are in LD and comprise
the sixth LD block in the gene (which includes SNPs
rs3176343,
rs3176344,
rs3176349,
rs1801270,
rs1059234, rs876581, rs6457938 and rs6457940). Table
3 shows analysis of haplotype structure using tagSNP
and estimated haplotype frequencies in this sixth block.
A 6-SNP haplotype comprising rs1801270 and
rs1059234 common alleles (GGGCCG) is more
prevalent in the LLI individuals compared to the
controls (91.0% vs 82.0%; p<0.002); the corresponding
frequencies for the 4-SNP haplotype of common alleles
are 90.4% vs. 81.9% (p<0.004). The significance of
these differences was confirmed by permutation
analysis.

Of those markers, 45 had high confidence calls on the
platform and two markers (CDKN1A29 and rs4711458)
were excluded because of the low call-rate. Of the
remaining SNPs, four (rs4711458, rs4714003,
CDKN1A7, rs6920453) were eliminated because the
genotype frequencies were not consistent with HardyWeinberg equilibrium in the control dataset or in the
entire sample. The association statistics for the
remaining 41 SNPs are presented in Table 2. Haplotype
frequencies were estimated using a sliding window
approach. Linkage disequilibrium (LD) analysis of the
p21 gene revealed the presence of seven blocks of
haplotype in the 60,000 bp region studied. Figure 2
shows a graphical representation of the blocks
identified. SNP analysis revealed the presence of two
minor alleles that were underrepresented in the LLI
compared to the non-LLI control populations, at SNPs
rs1801270 and rs1059234. Remarkably, these were the
only two exonic SNPs of all the SNPs analyzed. The
above mentioned rs1801270 consists of a base change
from AGC to AGA and amino acid changes from serine
to arginine at codon 31 in exon 2. SNP rs1059234
(p21C70T) consists of a C to T change in the 3'
untranslated region of the p21 gene, 20 bp following the
stop codon. Minor allele frequencies of SNP rs1801270
were 0.093 and 0.043 in controls and LLI respectively
(P< 0.02 chi-test). The corresponding minor allele
frequencies for SNP rs1059234 were 0.098 and 0.049
(P< 0.026 chi-test). No statistically significant
frequency differences were observed between LLI and
controls for the other (non-exonic) SNPs analyzed.

www.impactaging.com

DISCUSSION
In the present study, we have investigated possible
associations between longevity and SNPs in the p21
(CDKN1A) gene, which plays a role in stress response
and cell senescence, and increased expression of which
was shown to upregulate genes implicated in several
age-related diseases [6]. By sequencing the three exons
and 5 kb of the promoter region of p21, we have
identified many previously unknown or uncharacterized
SNPs in the p21 promoter. We have tested the activity
of the promoter derived from an LLI and containing a
cluster of minor alleles in the region between -4547 bp
and -3489 bp, where a novel p53 binding site has been
recently identified [7] and found no changes in the basal
activity or p53 responsiveness of this promoter. It
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should be noted, however, that there are many p53
independent physiological signals that induce p21,
where the response of the two alleles may potentially be
different. Interestingly the p21 promoter is induced by
some signals involved in stress response and inflamemation (such as TGFβ, INFγ, IL-6) that, as discussed
elsewhere, contribute to the pathogenesis of many agerelated diseases [9-11].

In a large case-control design study, we have compared
the frequency of 41 SNPs spanning the p21 gene
between large populations of LLI and younger Italian
individuals. Only two of 41 SNPs showed a statistically
significant difference between the two populations, and
remarkably, these were the only two exon-derived
SNPs. A 6-SNP haplotype comprising the common
alleles of these two SNPs was strongly overrepresented

Figure 2. Haplotype blocks distrubution in the p21 gene generated by Haploview. The two SNPs showing
significant differences in frequency between the centenarians and younger controls are bracketed. Every multimarker
combination within this block including the two SNPs is significant on the omnibus test for frequency distribution
among cases and controls. Table 3 gives the results of the haplotype test.
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among the centenarians relative to the control population.
One of these exonic SNPs (rs1801270) changes the
amino acid sequence of p21 from Ser to Arg at codon 31,
and the other (rs1059234) leads to a C->T transition 20
nucleotides downstream of the stop codon in the 3’
untranslated region. Remarkably, several studies suggested that the rare alleles of these two SNPs may play a
role in different types of cancer [12-17]. In particular, Li
et al. [12] have shown that, in non-Hispanic whites, the
rare versions of the rs1801270 and rs1059234 alleles are
associated to an increased risk susceptibility to squamous
cell carcinoma, individually and in combination. In
addition, Mousses at al. [18] observed that the rare alleles
of these two SNPs were under-represented in breast
cancer and sarcoma patients whose tumors possessed
somatic p53 mutations, as compared to tumors without
p53 mutations, suggesting that these alleles could
influence p21 functions in a p53-independent manner.

Longevity in humans can be defined as a multifactorial
condition to which both genetic and environmental
factors are likely to contribute. Twin studies have
shown that genetic differences account for about a
quarter of the variance in adult human lifespan. Despite
the challenges of studying complex traits such as
lifespan, studies have been reporting alleles that were
significantly associated with human longevity. One of
the best examples is APOE whose association has been
reproduced consistently [20-22]. The compression of
morbidity hypothesis proposed by James Fries in 1980
[23] postulates that as the limit of human lifespan is
approached, the onset and duration of lethal impairment
compresses toward the end of life. This ‘compression’
is observed in the majority of centenarians who are
often spared from age-related diseases, specifically
cardiovascular disease, Alzheimer disease, diabetes
mellitus, and cancer. To achieve their extreme age,
centenarians likely lack numerous gene variants that are
associated with age-related diseases and they may be
more likely to carry protective variants as well. Our
finding that the frequency of specific minor alleles of
p21 is decreased among Italian centenarians lends
additional support to this concept.

According to the data in the NCBI database (Entrez
SNP), the allele frequency distribution of the SNPs
rs1801270 and rs1059234 is highly variable and ethnicspecific. The frequency of the rs1801270 minor allele
varies from 0.021 (Europeans) to 0.47 (Asians) with
African-Americans, Sub-Saharan Africans, and
Hispanics having intermediate values. Similar values
are found for the rs1059234 rare allele, whose
frequencies vary from 0.021 (Europeans) to 0.45
(Asians), with African-Americans, Sub-Saharan
Africans, and Hispanics also having intermediate
values. This high ethnicity-related variability can
greatly complicate the interpretation of diseaseassociated studies, especially those conducted in multiethnic societies. In our large-scale study, we have used
a relatively homogenous Italian population. Our results
suggest that the presence of the rs1801270 and
rs1059234 rare alleles combined may be detrimental to
longevity and therefore negatively selected in Italian
LLI. Further large-scale studies could be useful to
compensate for genetic heterogeneity within the Italian
population and to clarify the potential role of these
SNPs in limiting the lifespan.

MATERIALS AND METHODS
Subjects. In the pilot study we used ten DNA samples
from LLI over 90 y.o. (white Americans of European
descent), including five females and five males. The
DNA samples, obtained from the NIA Aging Cell
Repository DNA panel, were obtained from CORIELL
bank (Camden, NJ). The second group of samples
comprised DNA from 92 non-centenarian subjects,
belonging to Utah/CEPH population, provided by
CORIELL bank. These samples were initially collected
from Utah residents with ancestry from northern and
western Europe. In the large case-control study, 184
Italians with exceptional longevity (mean age,
100.88±1.77 years) and a control group (38.97±12.21)
were recruited by the Bologna group in Central Italy,
after checking for ethnicity and ancestor origins. The
sex ratio in the Italian samples was 7 female to 1 male
in the centenarian group and 2:1 in the control group. A
full socioeconomic, quality of life and health status
assessment was performed. Primary criteria for
inclusion in the study were good health (for centenarians, subjects categorized A or B according to
Franceschi et al. [24] were included), physical activity
and absence of major diseases.

The mechanisms underlying the potential detrimental
effect of the rare alleles of rs1801270 and rs1059234
are presently unknown. The obvious hypotheses are that
the amino acid change at codon 31, which was proposed
to abolish p21 phosphorylation at Ser 31 [19], could
modulate its abilities to arrest the cell cycle or to induce
transcription of genes implicated in age-related
diseases, and that a nucleotide change in the 3’ UTR
could affect p21 mRNA stability or translational
efficiency. These possibilities remain to be tested in
future studies.
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p21 genotyping. We sequenced the three exons (68 bp,
450 bp, 1600 bp) and a 5 kb promoter region of the p21
(CDKN1A) gene in the DNA of ten LLI. The exons and
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the promoter were amplified by PCR in overlapping
fragments of ~ 400 bp each. The PCR primer pairs are
listed in Table 4, where p21pro.1 is the furthest from the
transcription start site. Primers were designed using the
primer3 software available at http://frodo.wi.mit.edu.
The primers were sized between 22-24 bases with a Tm
of 69-71oC and a GC content of 40-60 %. The primers
were checked for loops, hairpins and 3’ complementarity. The selected primers were synthesized by
idtDNA (Coralville, IA). The genomic DNA templates
were added to a master mix containing 2 μl of each
primer (10 μM), 5 μl Buffer (New England Biolabs,
Ipswich, MA), 2 μl of Taq polymerase (Invitrogen), and
water to the volume of 50 μl. The following PCR
profile was used: preincubation for 2 min at 96°C, 40
cycles of 30 sec at 95°C, 30 sec at the primer-specific
annealing temperature (Table 4) and 15 sec at 72°C, fol-

Name
p21.exon1.R
p21seq.exon1.F
p21seq.exon2.F
p21seq.exon2.R
p21seq.exon3.F1
p21seq.exon3.R1
p21seq.exon3.F2
p21seq.exon3.R2
p21seq.exon3.F3
p21seq.exon3.R3
p21pro1.r
p21pro1.F
p21pro2.f
p21pro2.r
P21.pro.3.f
P21.pro.3.r
P21pro4f
P21pro4r.
P21pro5f.
P21pro5r.
p21pro6.f
p21pro6.r
p21pro7.f
p21pro7.r
p21pro8.f
p21pro8.r
p21pro9.f
p21pro9.r
p21pro10.f
p21pro10.r
p21pro11.f
p21pro11.r

lowed by final incubation for 5 min at 72°C. Once
amplified, the fragments were purified with Millipore
columns (Millipore Billerica, MA) and then sequenced.
Sequencing was performed with ABI 3730 DNA
analyzer, using a Big Dye protocol with Zymo columnpurified products. Complete sequences were aligned,
assembled and compared using the Clone Manager
program. For verification, visual inspection of sequence
profiles for each candidate SNP was carried out. At least
two overlapping DNA templates amplified with different
primers were used for identification of each candidate
SNP. In addition to the SNP candidate approach, the
latest data available on the HapMap were analyzed, in
order to select an appropriate number of tagSNPs to
cover at least 90% of the genetic information in the locus
(r2=0.9 and MAF>0.05). The tagSNP and candidate SNP
sets were used for genotyping.

Sequence
AAGGCGAGCTCCCAGAAC
ACTGGGGGAGGAGGGAAGT
ACCAGCTGGAAGGAGTGAGA
GTCTTTGCTGCCTACTTGC
TGCGGTGATGGATAAAATCA
GAAAAGGAGAACACGGGATG
TCCTAAGAGTGCTGGGCATT
GCCCTTCTTCTTGTGTGTCC
TCTTCTCCAGCTGGGCTCT
CCCAAAAGCCCATTTATTTG
GGGGCTGCCTATGTAGTGAA
GTGCCACAGTTCACAAGTGC
TTTGCTTCTGGGCAGAACTT
CAGAGCCAGGATGAATTGGT
GATGTTGTTAGAGCCAGGAACAG
ATCAAGGCATAAAAATTTCATTGTG
AAAAGGTTTTTGAATGAATGGATG
AGAAGAGGCGGAACAAAGATAGAA
CACGCCCGGCCAGTATATATT TTT
GACAAAATAGCCACCAGCCTCTTCT
CACCTTTCACCATTCCCCTA
AGGGCTGGTTGTCAAATGTC
TGCATGGTTGCAAACTTTTT
TCACCTTTGCCTCCTTTCTG
AGGTCAGCTGCGTTAGAGGA
GGAAGGAGGGAATTGGAGAG
GGAGGCAAAAGTCCTGTGTT
ACATTTCCCCACGAAGTGAG
TCTAGGTGCTCCAGGTGCTT
CTGTGAACGCAGCACACAC
CCGAAGTCAGTTCCTTGTGG
GCTTCCTTGGGAACAAACTG

TM
60°
60°
58°
60°
58°
58°+ dmso
58°
54°
58.5°+dmso
58 °+ dmso
58°
54°
58°
54°
58° +dmso
54°

Table 4. Primer sequences and TM for amplifying the p21 gene.
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The SNP genotyping was performed using Sequenom’s
chip-based matrix assisted laser desorption/ionization
time-of-flight MS (DNA MASSARRAY). This technology performs allele-specific single-base primer
extension reactions, which allow differentiation of
homozygous normal, heterozygous mutant and homozygous mutant samples (iPLEX assay). The
MassEXTEND primers anneal up to the polymorphic
site and are extended with one single base. The allele
product masses depend on the SNP allele base and thus
they are easily distinguished with the mass
spectrometer. DNA of the Utah/CEPH population was
analyzed as a service by Sequenom (San Diego, CA) on
PCR-derived extension products from individual DNA
samples. Large-scale analysis of Italian samples was
performed by the Bologna group. Cases and controls
were always analyzed on the same chip to avoid
potential artifacts caused by chip–specific miscalls.

colon carcinoma cells, both wild type and p53-/sublines [8] (a gift of Dr. B. Vogelstein, Johns Hopkins
University) were grown in DMEM with Earle's salts
supplemented with 10% FCS and 2 mM L-glutamine in
a humidified 95% air 5% CO2 incubator. Cells were
seeded in 12-well tissue culture plates for 24 h prior to
transfection. When 70% confluent, the cells were
transfected with 1 μg of the indicated promoter–reporter
plasmids, together with pRL–TK Renilla luciferase
expressing plasmid (Promega, Madison, WI) to normalize for transfection efficiency, at a ratio of 10:1 test
vector:standard vector. Transfections were performed in
triplicate, using FuGENE6 (Roche Molecular Biochemicals). A precipitate was formed using 3 μl of
FuGENE6/μg of transfected DNA and the transfection
mixture was diluted up to 1 ml with serum-free
medium. After incubation at 22°C for 10 min, the
DNA/FuGENE6 mixture was added to cells. Cells were
harvested 48 h after transfection, and firefly and Renilla
luciferase activities were measured.

Plasmid constructs. The plasmid p21-PGL.4.10-luc
containing the 5 kb p21 promoter comprising the
common alleles and driving firefly luciferase expression
has been previously described [7]. This plasmid was
used to replace a cluster of common SNP alleles in the
promoter with the minor alleles, contained within a
fragment of ~2.1 kb, which was amplified by doubleround PCR from genomic DNA of a LLI. PCR was
carried out using a proofreading polymerase, Phusion™
Hot Start High-Fidelity DNA Polymerase (New
England Biolabs, Ipswich, MA). The primed template
was pre-formed in the presence of 5X Phusion GC
buffer (New England Biolabs, Ipswich, MA) and 200
µM of each dNTP, 0.5 μM primers, and 1 U of Phusion
DNA polymerase. The template being GC-rich, 3%
DMSO was added to optimize the product yield. The
samples were incubated as follows: preincubation for 30
sec at 98°C, 30 cycles of 10 sec at 98°C, 30 sec at 66°C
and 3 min at 72°C and one final incubation for 5 min at
72°C. In the first round, the 5kb PCR product of the p21
promoter was amplified using the following primers:
p21-4997F TACAAACATTGGGTGGGGCGAGTC
p21-R-44 CTCCGGCTCCACAAGGAACTGACTT
In the second round, this PCR product was used as a
template to generate a PCR product of ~2.1 kb using the
following primers:
p21-4497F TACAAACATTGGGTGGGG CGAGTC
p21-5R GACAAAATAGCCACCAGCCTCTTCT
The latter PCR product was digested with AatII and Sph
restriction enzymes (New England Biolabs), and cloned
into p21-PGL.4.10-luc plasmid digested with the same
enzymes, replacing the corresponding fragment
containing the common alleles. The resulting plasmid
was sequence-verified and designated p21R-luc.

Statistical analysis. We tested departure from HardyWeinberg equilibrium [25] in the controls by a 2 test
using P = 0.01 as threshold. This threshold was chosen
based on anticonservativeness of this test as noted by
Wigginton [25]. All SNPs (except for rs4711458,
rs4714003, CDKN1A7, rs6920453) were in HardyWeinberg equilibrium. Each SNP was tested both with
basic association testing based on comparing allele
frequencies between cases and controls (asymptotic and
empirical p-value to control for multiple testing), and
with Conchran-Armitage trend test in a dominant,
recessive and general model.
Multi-locus haplotype analysis was performed by using
a sliding-window approach implemented in PLINK [26]
for multi-loci of 4 or 6 SNPs size. Multimarker haplotypes have been estimated by using the E-M algorithm
implemented in the software. An LD map of the region
has been produced by using the software Haploview
[27] in order to identify LD blocks within the typed
markers. The haplotype blocks identified have been
tested in the same way, i.e. phased and used for
frequency estimation by E-M algorithm and chi-square
testing of the frequencies.
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